COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds

Thromb Res. 2024 Mar:235:8-10. doi: 10.1016/j.thromres.2024.01.005. Epub 2024 Jan 12.

¹ Department of Cardiovascular Diseases, Division of Vascular Medicine, Rochester, MN, United States of America; Department of Internal Medicine, Division of Hematology, Mayo Clinic, MN, United States of America. Electronic address: Houghton.Damon@mayo.edu.
² Department of Cardiovascular Diseases, Division of Vascular Medicine, Rochester, MN, United States of America.
³ Department of Cardiovascular Diseases, Division of Vascular Medicine, Rochester, MN, United States of America; Department of Internal Medicine, Division of Hematology, Mayo Clinic, MN, United States of America.
⁴ Department of Internal Medicine, Division of Hematology/Oncology, Mayo Clinic, AZ, United States of America.
⁵ Department of Internal Medicine, Division of Hematology/Oncology, Mayo Clinic, FL, United States of America.
⁶ Department of Internal Medicine, Division of Hematology, Mayo Clinic, MN, United States of America.
⁷ Department of Emergency Medicine, Mayo Clinic, MN, United States of America.

No abstract available

Keywords: COVID-19; Pulmonary embolism, D-dimer; SARS-CoV-2; Venous thromboembolism.

Publication types